3
September 14 – 16, 2020 Alliance Leadership As a Catalyst for a Better Tomorrow Platinum Sponsors www.strategic-alliances.org tinyurl.com/LinkedINASAP-Co www.facebook.com/ASAPGlobal @asap_Global As of 07.10.20 Details subject to change. Virtual Agenda Virtual Agenda Livestream Agenda On-Demand Agenda

Virtual Agenda · Chandra Ramanathan, PhD | Global Head, Pharma R&D Open Innovation | Bayer U.S. Kenji Shigeta | Vice President, DS-8201 Business Strategy, Global Brand Strategy Unit

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Virtual Agenda · Chandra Ramanathan, PhD | Global Head, Pharma R&D Open Innovation | Bayer U.S. Kenji Shigeta | Vice President, DS-8201 Business Strategy, Global Brand Strategy Unit

September 14 – 16, 2020

Alliance Leadership As a Catalyst for a Better Tomorrow

Platinum Sponsors

www.strategic-alliances.org tinyurl.com/LinkedINASAP-Co www.facebook.com/ASAPGlobal @asap_Global

As of 07.10.20 Details subject to change.

Virtual AgendaVirtual Agenda

Livestream Agenda On-Demand Agenda

Page 2: Virtual Agenda · Chandra Ramanathan, PhD | Global Head, Pharma R&D Open Innovation | Bayer U.S. Kenji Shigeta | Vice President, DS-8201 Business Strategy, Global Brand Strategy Unit

page 22020 Virtual BioPharma Conference—Alliance Leadership As a Catalyst for a Better Tomorrowwww.asapbiopharma.org

More specifics regarding session content and schedule is forthcoming. Speakers and topics are subject to change.

As of 07.10.20 Details subject to change.

Monday, September 14, 2020

Time Session

9:30 a.m. – 10:00 a.m. Virtual Breakfast Tables

11:00 a.m. – 2:00 p.m. Livestream programming including keynotes and executive panel discussions

2:00 p.m. – 2:30 p.m. Virtual Hallway Discussions

2:30 p.m. – 4:15 p.m. ASAP BioPharma Conference Roundtable Discussions

Livestream Agenda

Tuesday, September 15, 2020

Time Session

9:30 a.m. – 10:00 a.m. Virtual Breakfast Tables

11:00 a.m. – 2:00 p.m. Livestream programming including keynotes and executive panel discussions

2:00 p.m. – 2:30 p.m. Virtual Hallway Discussions

Thursday, September 16, 2020

Time Session

9:30 a.m. – 10:00 a.m. ASAP BioPharma Conference Roundtable Discussions

11:00 a.m. – 2:00 p.m. Livestream programming including keynotes and executive panel discussions

2:00 p.m. – 2:30 p.m. Virtual Hallway Discussions

Rusty Field President & CEO

Upsher-Smith Laboratories, LLC

Melinda Richter Global Head of JLABS

Johnson & Johnson Innovation

Edward CoxExecutive VP Strategic Alliances & Global Head of Digital Medicine

EVERSANA

Derek DanoisChief Data Officer

GE Healthcare

Livestream Keynote Speakers Include:

Page 3: Virtual Agenda · Chandra Ramanathan, PhD | Global Head, Pharma R&D Open Innovation | Bayer U.S. Kenji Shigeta | Vice President, DS-8201 Business Strategy, Global Brand Strategy Unit

More specifics regarding session content and schedule is forthcoming. Speakers and topics are subject to change.

As of 07.10.20 Details subject to change.

Other Livestream Speakers, Panelists, and Moderators Include:

Jonathon Bell | Director, Alliance and Integration Management | AstraZeneca

Christine Carberry, CSAP | Principal | Carberry Consulting

Liz Gazda | CEO | Embr Labs

Stu Kliman, CA-AM | Founding Partner | Vantage Partners

Yaminah Leggett-Wells | Senior Director, Project Management | Viela Bio

Chris Lento | Head of Healthcare Strategic Partnerships | Noom

Brooke Paige, CSAP

Davina Pallone | Vice President, Product | Fruit Street

Chandra Ramanathan, PhD | Global Head, Pharma R&D Open Innovation | Bayer U.S.

Kenji Shigeta | Vice President, DS-8201 Business Strategy, Global Brand Strategy Unit | Daiichi Sankyo

Jeff Shuman, CSAP, PhD | Principal | The Rhythm of Business

Ben Siddall | Partner | Vantage Partners

Knut Sturmhoefel, CA-AM, PhD | Global Head Novartis Alliance Management | Novartis International

Jan Twombly, CSAP | President | The Rhythm of Business

Livestream Agenda

On-Demand Session Speakers Include:

David Andrews, PhD | Pre-clinical Director, External R&D and Strategic Alliances | AstraZeneca

Sarah Batey, PhD | Vice President, Project & Portfolio Management | F-star Therapeutics Ltd

Dimitri Fillos | Senior Alliance and Partnerships Leader, Clinical Operations | Genentech Research and Early Development

Julie Little | Strategic Alliance Executive | Cancer Research UK

Jessica Piggee |Senior Alliance and Partnership Leader, gRED Clinical Operations | Genentech, A Member of the Roche Group

Louis Rinfret | Founder & CEO | allianceboard

Michael Roch | Chief Commercial Officer | allianceboard

Kristina Tubby, PhD | Strategic Alliance Manager | Cancer Research UK

Jan Twombly, CSAP | President | The Rhythm of Business

Margarita Wucherer-Plietker, CA-AM, PhD | Director Alliance Management | Merck Healthcare KGaA

On-Demand Agenda

page 32020 Virtual BioPharma Conference—Alliance Leadership As a Catalyst for a Better Tomorrowwww.asapbiopharma.org